Characterizing TUNA® ablative treatments of the prostate for benign hyperplasia with gadolinium-enhanced magnetic resonance imaging

Journal of Endourology

Volumn 21, Issue 11, 2007, Pages 1361-1366

  Mynderse, Lance A ^a   Larson, Benjamin ^c   Huidobro, Christian ^d   Meyer, James J ^e   Busel, David ^d   Hanson, Dennis P ^b   Larson, Thayne ^f  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF CHILE   (Chile)

^e Urologic Physicians   (United States)

^f Institute of Medical Research Scottsdale   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER PROGRAM; CONTRAST ENHANCEMENT; HUMAN; MALE; NEEDLE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN SIZE; PRIORITY JOURNAL; PROSTATE; PROSTATE HYPERTROPHY; PROSTATE SURGERY; RECTUM; SURGICAL TECHNIQUE; URETHRA; URINARY TRACT DISEASE; METHODOLOGY; MIDDLE AGED; NECROSIS; PATHOLOGY; TRANSURETHRAL RESECTION;

AGED; GADOLINIUM; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NECROSIS; PROSTATE; PROSTATIC HYPERPLASIA; TRANSURETHRAL RESECTION OF PROSTATE;

EID: 36549064705     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2007.0029     Document Type: Article

References (14)

1. Boyle P, Robertson C, Vaughan ED, et al. A meta-analysis of trials of transurethral needle ablation for treating symptomatic benign prostatic hyperplasia. BJU Int 2004;94:83.
2. Braun M, Mathers M, Bondarenko B, et al. Treatment of benign prostatic hyperplasia through transurethral needle ablation (TUNA): Review of the literature and six years of clinical experience. Urol Int 2004;72:32.
3. Bruskewitz R, Issa MM, Roehrborn CG, et al. A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia. J Urol 1998;159:1588.
4. Chapple CR, Issa MM, Woo H. Transurethral needle ablation (TUNA): A critical review of radiofrequency thermal therapy in the management of benign prostatic hyperplasia. Eur Urol 1999;35:119.
5. Hill B, Belville W, Bruskewitz R, et al. Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5-Year results of a prospective, randomized, multicenter clinical trial. J Urol 2004;171:2336.
6. Ramon J, Lynch TH, Eardley I, et al. Transurethral needle ablation of the prostate for the treatment of benign prostatic hyperplasia: A collaborative multicentre study. Br J Urol 1997;80:128.
7. Steele GS, Sleep DJ. Transurethral needle ablation of the prostate: A urodynamic-based study with 2-year follow up. J Urol 1997;158:1834.
8. Zlotta AR, Giannakopoulos X, Maehlum O, et al. Long-term evaluation of transurethral needle ablation of the prostate (TUNA) for treatment of symptomatic benign prostatic hyperplasia: Clinical outcome up to five years from three centres. Eur Urol 2003;44:89.
9. Harewood LM, Cleeve LK, O'Connell HE, et al. Transurethral needle ablation of the prostate (TUNA): Clinical results and ultrasound, endoscopic, and histologic findings in pilot study of patients in urinary retention. J Endourol 1995;9:407.
10. Larson BT, Bostwick DG, Corica AG, et al. Histological changes of minimally invasive procedures for the treatment of benign prostatic hyperplasia and prostate cancer: Clinical implications. J Urol 2003;170:12.
11. Rasor JS, Zlotta AR, Edwards SD, et al. Transurethral needle ablation (TUNA): Thermal gradient mapping and comparison of lesion size in a tissue model and in patients with benign prostatic hyperplasia. Eur Urol 1993;24:411.
12. Schulman CC, Zlotta AR. Transurethral needle ablation (TUNA): Histopathological, radiological and clinical studies of a new office procedure for treatment of benign prostatic hyperplasia. Prog Clin Biol Res 1994;386:479.
13. Larson BT, Collins JM, Huidobro C, et al. Gadolinium-enhanced MRI in the evaluation of minimally invasive treatments of the prostate: Correlation with histopathologic findings. Urology 2003;62:900.
14. Osman YM, Larson TR, El-Diasty T, et al. Correlation between central zone perfusion defects on gadolinium-enhanced MRI and intraprostatic temperatures during transurethral microwave thermotherapy. J Endourol 2000;14:761.